Separator

DocOsage Secures Pre-Seed Funding from Angel Investor Mayur Agarwal

Separator
AI-driven health platform, DocOsage, secures pre-seed funding led by Angel Investor Dr. Mayur Agarwal. The funding is earmarked for advancing product development, strengthening Core-AI capabilities for health insights, and conducting initial testing for telehealth and genetic studies. Established in October 2023 by Varun Vashisthaa, Dr. Shivali Agarwal, and Dr. Lipi Verma, DocOsage is positioned as a groundbreaking lifelong health companion app. It facilitates specialized healthcare communities for collaborative treatment plans and contributes to national healthcare enhancement.

Varun Vashisthaa, CEO and Co-Founder of DocOsage, underscores the commitment to revolutionizing healthcare through cutting-edge technology. The initial funding serves as a catalyst for launching product development, marking a significant step toward creating an innovative health platform. Dr. Lipi Verma(PT), Co-founder and Chief Medical Officer of DocOsage, expresses the ambition to empower individuals and families through accessible, technology-driven healthcare solutions. The pre-seed round accelerates foundational development for their pioneering health platform.

DocOsage ensures convenience by offering home delivery of medicines, streamlined booking of investigations and diagnostics and easy report sharing. The platform leverages AI for personalized health insights and has plans to integrate telehealth and genetic testing for comprehensive care. Investor and Advisor, Dr. Mayur Agarwal, acknowledges, "DocOsage is not just an app; it's a healthcare revolution". He recognizes the immense potential in DocOsage's vision and is enthusiastic about supporting the early stages of their groundbreaking health tech solution. As DocOsage prepares for growth, it prioritizes Product Refinement through iterative development, Strategic Partnerships with hospitals and clinics, and Future Capital Infusion for scaling and expanding offerings.